BOSTON – (September 22, 2016) – Robert C. Stanton, M.D., Chief of the Kidney and Hypertension Section and Principal Investigator in the Section on Vascular Cell Biology at Joslin Diabetes Center and Associate Professor of Medicine at Harvard Medical School, received a 2016 Harvard Medical School (HMS) Special Faculty Prize for Sustained Excellence in Teaching.

Since 2006, HMS has recognized a highly select group of the school’s most outstanding educators with the Faculty Prize for Excellence in Teaching to faculty members who have made long-standing and enduring contributions to the education of Harvard medical students.

Dr. Stanton is involved with teaching at all levels (student, resident, fellow, and faculty) at local, national, and international levels. He has made many important contributions to the education of Harvard medical students during the more than 30 years he taught renal physiology and pathophysiology at HMS, including being the Director of the Second Year Renal Pathophysiology Course and Co-Director of Human Systems Pathophysiology Course. His outstanding contributions to teaching at HMS have launched generations of medical students as confident and well- educated physicians.

“Receiving this award was unexpected and I am deeply honored and grateful to be considered part of this highly selected group of people,” said Dr. Stanton. “I have always felt that teaching is critically important; not only does teaching medical students, residents, fellows, and clinical colleagues improve the care of our patients, but it has enabled me to learn from those whom I have taught and grow as both a physician and human being.”

In addition to his clinical and teaching responsibilities, Dr. Stanton also conducts research aimed at determining the basic cellular mechanisms responsible for diabetic kidney disease, for the death of pancreatic beta cells, and for cardiovascular disease in people with diabetes. 

“Dr. Stanton has been a true ‘triple threat’- a dedicated clinician, outstanding researcher and a gifted mentor,” said Robert A. Gabbay, M.D., Ph.D., Chief Medical Officer at Joslin Diabetes Center and Associate Professor of Medicine at Harvard Medical School.”  “He is responsible for an entire generation of Harvard medical students learning the fundamentals of pathophysiology as it relates to diabetes and we are very proud of his well-deserved recognition.” 

Dr. Stanton has been invited to lecture throughout the United States and throughout the world (including China, India, the Middle East, Europe, and South America). He has received three Honorary Professorships from Universities in China. He is an author of many original articles and chapters, and serves both in reviewer and in editorial positions for academic journals.

The Harvard Medical School Special Faculty Prize for Sustained Excellence in Teaching was awarded at the Daniel D. Federman Teaching Awards Celebration on Monday, September 12, 2016 in the TMEC Walter Amphitheatre.

***

Related Articles

A Scientist working in lab
Type 1
Kidney Disease
Research Highlights

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion

Three-year clinical trial finds reducing uric acid levels in type 1 diabetes provides no beneficial impact on the progression of diabetic kidney disease BOSTON – (November 8, 2019) – Diabetic kidney...
Read more on The Preventing Early Renal Loss in Diabetes (PERL) Study Conclusion
National Diabetes Month
Type 1
Type 2

National Diabetes Awareness Month

National Diabetes Awareness Month

Diabetes is growing at an epidemic rate in the United States and across the globe. According to the Centers for Disease Control and Prevention (CDC), over 30 million Americans have diabetes and 1.5...
Read more on National Diabetes Awareness Month
Red blood cell traveling in an artery
Type 1
Heart Disease
Research Highlights

Research may show way to minimize complications after heart treatment

Research may show way to minimize complications after heart treatment

BOSTON – (October 1, 2019) – People with diabetes are much more likely to develop heart disease than those without the condition. They also are several times more likely to develop complications after...
Read more on Research may show way to minimize complications after heart treatment